Current disease status-In remission-Remission after first occurrence Posts on Medivizor
Navigation Menu

Current disease status-In remission-Remission after first occurrence Posts on Medivizor

Decitabine, cytarabine and umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia

Posted by on Sep 17, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the combination of low-dose decitabine, medium-dose cytarabine and umbilical cord blood infusion as a consolidation therapy for elderly patients with acute myeloid leukemia.   This study concluded that this treatment combination was effective in these patients.   Some...

Read More

Anti-thymocyte globulin to prevent complications after transplant in patients with acute lymphoblastic leukemia

Posted by on May 2, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the effect of anti-thymocyte globulin on the outcomes of allogeneic peripheral blood stem cell transplantation in patients with Philadelphia negative acute lymphoblastic leukemia. This study concluded that this group of patients benefited from the use of anti-thymocyte globulin. Some background Stem cell...

Read More

What are the long-term outcomes following bendamustine treatment?

Posted by on Mar 12, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the long-term safety and effectiveness of bendamustine (Treanda) in lymphoma and leukemia. This study concluded that bendamustine is a safe and effective therapy for these patients. Some background Bendamustine has been shown to have high effectiveness and few side effects for a wide range of lymphomas. This drug is...

Read More

What are the long-term outcomes following bendamustine treatment?

Posted by on Mar 12, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the long-term safety and effectiveness of bendamustine (Treanda) in lymphoma and leukemia. This study concluded that bendamustine is a safe and effective therapy for these patients. Some background Bendamustine has been shown to have high effectiveness and few side effects for a wide range of lymphomas. This drug is...

Read More

Stem cell transplants in older patients with acute lymphoblastic leukemia

Posted by on Mar 7, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcome for patients aged over 60 who underwent reduced intensity allogeneic stem cell transplant. This study concluded that a subset of these patients will have extended survival and disease-free state following treatment. Some background Hematopoietic stem cell transplantation (HSCT) is increasingly...

Read More

Searching for acute myeloid leukemia patients in remission to test a new maintenance therapy

Posted by on Feb 5, 2018 in Leukemia | 0 comments

In a nutshell This phase 3 trial aims to evaluate the efficacy of gilteritinib as a maintenance therapy for acute myeloid leukemia (AML) patients to prevent cancer returning. The main outcomes to be investigated are relapse free survival and overall survival.  The details Gilteritinib is a kinase inhibitor. It works by binding and inhibiting...

Read More

Sticking to maintenance therapy after remission reduces relapse risk in childhood ALL

Posted by on Mar 25, 2017 in Leukemia | 0 comments

In a nutshell This study examined the effect of adherence to maintenance therapy on relapse risk in Hispanic and non-Hispanic children with acute lymphoblastic leukemia (ALL). Researchers concluded that lower adherence to maintenance therapy increases relapse risk. Ethnic differences in relapse risk differed depending on the level of adherence. Some...

Read More